Clinical Trials Directory

Trials / Completed

CompletedNCT02032251

Reduction of Sperm DNA Fragmentation by Oral Ginger

Reduction of Sperm DNA Fragmentation by Oral Ginger (Zingiberofficinale) Extract Treatment

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
71 (actual)
Sponsor
Royan Institute · Other Government
Sex
Male
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study is a randomized, double blind, controlled clinical trials assess the efficacy of the ginger oral treatment on sperm DNA fragmentation, sperm parameters and male hormones.

Detailed description

Sperm DNA fragmentation is known to affect male fertility. Previous findings have suggested the implication of oxidative stress in the etiology of this pathological condition. The present study was designed to find out DNA fragmentation in ejaculated spermatozoa can be reduced by oral treatment with Ginger extract. 71 men with unexplained or Idiopathic infertility were randomized between a Ginger treatment (500 milligram daily for 3months) group and a placebo group. Sperm DNA fragmentation was evaluated by Terminal deoxyribonucleotidyltransferase-mediated dUTP nick-end labeling assay (TUNEL) before and after treatment. No differences in basic sperm parameters were found between the Ginger treatment and the placebo group before or after treatment. However, the percentage of DNA-fragmented spermatozoa was markedly reduced (P\< .005) in the Ginger treatment group after the treatment as compared with the pretreatment values). No difference in the pretreatment and post treatment incidence of sperm DNA fragmentation was observed in the placebo group. These data show that sperm DNA damage can be efficiently treated with oral Ginger extract administered during a relatively short time period.

Conditions

Interventions

TypeNameDescription
DRUGoral administration of gingerOral administration of ginger in patients with infertility.
DRUGPlacebo

Timeline

Start date
2009-12-01
Primary completion
2010-09-01
Completion
2010-11-01
First posted
2014-01-09
Last updated
2014-01-09

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT02032251. Inclusion in this directory is not an endorsement.